Neuren Pharmaceuticals Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neuren Pharmaceuticals Ltd with three other companies in this sector in Australia: Invitrocue Ltd (2017 sales of 710,085.91 Australian Dollars [US$533,899.40 ] ), Opthea Ltd (573,421.00 Australian Dollars [US$431,143.78 ] ), and Novita Healthcare Ltd (566,156.00 Australian Dollars [US$425,681.37 ] ).

Sales Analysis. During the year ended December of 2017, sales at Neuren Pharmaceuticals Ltd were A$678,000.00 (US$509.77 thousand). This is a sharp decrease of 54.6% versus 2016, when the company's sales were A$1.49 million.